Nanobodies Market Is Estimated To Witness High Growth
Nanobodies Market The nanobodies market is estimated to be valued at US$ 368.6 Million Or Mn In 2022 and is expected to exhibit a CAGR of 24.1% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Nanobodies are single-domain antibody fragments derived from heavy-chain antibodies found naturally in Camelidae including camels, dromedaries, alpacas, and llamas. Nanobodies offer advantages over conventional antibodies such as simple and economical production, high specificity and affinity to antigens, thermal stability, and neutral pH range. Their small size allows them to bind cryptic epitopes and address applications where conventional antibodies do not work. Owing to these advantages, nanobodies are increasingly being used as substitutes to traditional monoclonal antibody therapeutics. Market key trends: One of the key trends driving the growth of the nanobodies market is the increasing demand for monoclonal anti...